Mereo BioPharma Group (MREO) Insider Trading & Ownership $3.35 +0.06 (+1.82%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Mereo BioPharma Group (NASDAQ:MREO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.13%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$1.28 M Get MREO Insider Trade Alerts Want to know when executives and insiders are buying or selling Mereo BioPharma Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MREO Insider Buying and Selling by Quarter Ad ProsperityPubThis Indicator called BOTH NVDA ralliesRarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… Click this link here. Mereo BioPharma Group Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/12/2024Charles SermonGeneral CounselSell9,980$4.47$44,610.60 9/12/2024Christine Ann FoxCFOSell9,128$4.47$40,802.16 9/12/2024Denise Scots-KnightCEOSell28,611$4.47$127,891.17 9/12/2024John A LewickiInsiderSell5,212$4.47$23,297.64 8/22/2024Deepika PakianathanDirectorSell105,244$4.43$466,230.92 6/25/2024Charles SermonGeneral CounselSell14,202$3.69$52,405.38 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/25/2024Christine Ann FoxCFOSell12,990$3.69$47,933.10 6/25/2024Denise Scots-KnightCEOSell40,712$3.69$150,227.28 6/25/2024John A LewickiInsiderSell7,416$3.69$27,365.04 5/22/2024Alexandra Hughes-WilsonInsiderSell100,432$2.97$298,283.04 (Data available from 1/1/2013 forward) MREO Insider Trading Activity - Frequently Asked Questions Who is on Mereo BioPharma Group's Insider Roster? The list of insiders at Mereo BioPharma Group includes Alexandra Hughes-Wilson, Charles Sermon, Christine Ann Fox, Deepika Pakianathan, Denise Scots-Knight, and John A Lewicki. Learn more on insiders at MREO. What percentage of Mereo BioPharma Group stock is owned by insiders? 4.13% of Mereo BioPharma Group stock is owned by insiders. Learn more on MREO's insider holdings. Which Mereo BioPharma Group insiders have been selling company stock? The following insiders have sold MREO shares in the last 24 months: Alexandra Hughes-Wilson ($298,283.04), Charles Sermon ($97,015.98), Christine Ann Fox ($88,735.26), Deepika Pakianathan ($466,230.92), Denise Scots-Knight ($278,118.45), and John A Lewicki ($50,662.68). How much insider selling is happening at Mereo BioPharma Group? Insiders have sold a total of 333,927 Mereo BioPharma Group shares in the last 24 months for a total of $1,279,046.33 sold. Mereo BioPharma Group Key ExecutivesDr. Denise Vera Scots-Knight Ph.D. (Age 65)Co-Founder, CEO & Executive Director Compensation: $890.56kMr. Charles Edward Sermon (Age 55)Co-Founder, General Counsel, Business Development & Company Secretary Compensation: $625.79kMs. Christine Fox CPA (Age 43)Chief Financial Officer Compensation: $569.77kDr. John P. Richard M.B.A. (Age 67)Co-Founder & Chief Business Officer Dr. John A. Lewicki Ph.D. (Age 72)Chief Scientific Officer Dr. Jackie Parkin (Age 66)Senior VP & Therapeutic Head Ms. Alexandra Hughes-Wilson (Age 53)Chief of Patient Access & Commercial Planning Dr. Suba Krishnan (Age 59)Senior Vice President of Clinical Development Mr. Bo KaraSenior VP and Head of Pharmaceutical Development & CMC More Insider Trading Tools from MarketBeat Related Companies Akero Therapeutics Insider Ownership Amphastar Pharmaceuticals Insider Ownership Tarsus Pharmaceuticals Insider Ownership Disc Medicine Insider Ownership CG Oncology Insider Ownership Harmony Biosciences Insider Ownership Xencor Insider Ownership Arcutis Biotherapeutics Insider Ownership Nurix Therapeutics Insider Ownership Arcus Biosciences Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:MREO) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mereo BioPharma Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Mereo BioPharma Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MREO Stock Alerts